SHINVA(SH:600587) Xin Lang Cai Jing·2025-09-18 06:00Core Viewpoint - Xinhua Medical's stock price has shown fluctuations, with a recent decline of 2.10% and a total market capitalization of 10.192 billion yuan, indicating potential investor concerns and market dynamics [1]. Financial Performance - For the first half of 2025, Xinhua Medical reported operating revenue of 4.79 billion yuan, a year-on-year decrease of 7.64%, and a net profit attributable to shareholders of 386 million yuan, down 20.35% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 812 million yuan, with 455 million yuan distributed over the last three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for Xinhua Medical reached 39,300, an increase of 0.82% from the previous period, while the average circulating shares per person decreased by 0.81% to 15,386 shares [2]. - The top three circulating shareholders include Huabao Zhongzheng Medical ETF, holding 16.0931 million shares (an increase of 196,600 shares), and Hong Kong Central Clearing Limited, holding 7.9202 million shares (an increase of 413,000 shares) [3]. Business Overview - Xinhua Medical, established on April 18, 1993, and listed on September 27, 2002, operates primarily in the medical device and pharmaceutical equipment sectors, with a revenue composition of 35.16% from medical device manufacturing, 31.23% from medical trade, 24.43% from pharmaceutical equipment, 7.05% from medical services, and 2.12% from other sources [1]. - The company is categorized under the pharmaceutical and biological industry, specifically in medical devices and equipment, and is involved in various concept sectors including mid-cap, medical waste treatment, in vitro diagnostics, smart healthcare, and private hospitals [1].